{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:12:52Z","timestamp":1758039172567,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ad.2017.08.015","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T23:30:13Z","timestamp":1512171013000},"page":"749-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inflamaci\u00f3n de queratosis act\u00ednicas durante el tratamiento con panitumumab"],"prefix":"10.1016","volume":"109","author":[{"given":"M.M.","family":"Escudero-G\u00f3ngora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.J.","family":"del Pozo-Hernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Corral-Maga\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ant\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2017.08.015_bib0055","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/annonc\/mdi279","article-title":"Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors","volume":"16","author":"Segaert","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ad.2017.08.015_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1067\/mjd.2000.103344","article-title":"Histopathology of incipient intraepidermal squamous cell carcinoma (\u00abactinic keratosis\u00bb)","volume":"42","author":"Cockerell","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.08.015_bib0065","first-page":"1303","article-title":"Actinic keratosis: Correlation between clinical and histological classification systems","volume":"30","author":"Schmitz","year":"2016","journal-title":"JEADV"},{"key":"10.1016\/j.ad.2017.08.015_bib0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2014.07.032","article-title":"Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane","volume":"72","author":"Macdonald","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.08.015_bib0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ad.2013.11.013","article-title":"Spanish adaptation of the European guidelines for the evaluation and treatment of actinic keratosis","volume":"105","author":"Ferr\u00e1ndiz","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2017.08.015_bib0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archderm.139.1.77","article-title":"Cutaneous reactions to chemotherapy drugs: The art of consultation","volume":"139","author":"Remlinger","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2017.08.015_bib0085","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1365-4632.2011.05265.x","article-title":"Improvement of actinic keratosis associated with sunitinib therapy for metastatic renal cell carcinoma","volume":"52","author":"Mir-Bonaf\u00e9","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2017.08.015_bib0090","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2230.2006.02223.x","article-title":"Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosinekinase inhibitor","volume":"31","author":"Lacouture","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2017.08.015_bib0095","first-page":"581","article-title":"Erlotinib-responsive actinic keratoses","volume":"18","author":"Hermanns","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ad.2017.08.015_bib0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000367959","article-title":"Dysregulation of epidermal growth factor receptor in actinic keratosis and squamous cell carcinoma","volume":"46","author":"Joseph","year":"2015","journal-title":"Curr Probl Dermatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017306038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017306038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:08:51Z","timestamp":1757552931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731017306038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0001731017306038"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2017.08.015","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflamaci\u00f3n de queratosis act\u00ednicas durante el tratamiento con panitumumab","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2017.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}